Toripalimab Combined With Chemotherapy and Bevacizumab as First-Line Treatment in Patients With Advanced Cervical Cancer

NCT04973904 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

35

Enrollment

OTHER

Sponsor class

Conditions

Cervical Cancer

Interventions

DRUG: Toripalimab
DRUG: Paclitaxel
DRUG: Cisplatin
DRUG: Bevacizumab

Sponsor

Peking Union Medical College Hospital